CN
Contact Us
010-69739712
WeChat
CN
EN
Home
About Us
Company Profile
Company Culture
Team Introduction
Products Services
Tumor Cell Therapy
Inspection of Immune Function
News
Company News
Industry News
R & D Center
R & D Introduction
Technology Platform
R & D Results
Contact Us
Contact
Talent Recruitment
R & D Introduction
Technology Platform
R & D Results
The company takes the immune cell therapy of hematological tumors and solid tumors as the main research and development direction, and establishes targeted cell therapy with CAR-T and CAR-NK as the main technology platform.
